Terumo EBITDA 2012-2024 | TRUMY
- Terumo EBITDA for the quarter ending September 30, 2024 was $0.420B, a 149.93% increase year-over-year.
- Terumo EBITDA for the twelve months ending September 30, 2024 was $1.201B, a 36.15% increase year-over-year.
- Terumo 2024 annual EBITDA was $1.496B, a 7.79% increase from 2023.
- Terumo 2023 annual EBITDA was $1.388B, a 10.8% decline from 2022.
- Terumo 2022 annual EBITDA was $1.556B, a 8.68% increase from 2021.
Terumo Annual EBITDA (Millions of US $) |
|
---|---|
2024 | $1,496 |
2023 | $1,388 |
2022 | $1,556 |
2021 | $1,432 |
2020 | $1,499 |
2019 | $1,356 |
2018 | $1,355 |
2017 | $1,145 |
2016 | $1,049 |
2015 | $989 |
2014 | $1,052 |
2013 | $1,038 |
2012 | $1,167 |
Terumo Quarterly EBITDA (Millions of US $) |
|
---|---|
2024-06-30 | $420 |
2023-06-30 | $216 |
2022-06-30 | $234 |
2021-06-30 | $330 |
2020-06-30 | $168 |
2019-06-30 | $265 |
2018-06-30 | $238 |
2017-06-30 | $210 |
2016-06-30 | $199 |
2015-06-30 | $159 |
2015-03-31 | $1,061 |
2014-12-31 | $1,143 |
2014-09-30 | $1,136 |
2014-06-30 | $155 |
2014-03-31 | $1,221 |
2013-12-31 | $1,192 |
2013-09-30 | $1,161 |
2013-06-30 | $135 |
2013-03-31 | $1,289 |
2012-12-31 | $1,278 |
2012-09-30 | $1,219 |
2012-06-30 | $194 |
2012-03-31 | $1,242 |
2011-12-31 | $1,267 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $26.961B | $6.386B |
Terumo Corporation is engaged in the manufacture and sales of medical products and equipment. The products offered by the Company covers General Hospital Products, Cardiac & Vascular Products, Blood Transfusion Products and Consumer Healthcare Products. General hospital products offered by it include Disposable Medical Equipment, Medical Electronic Products, Diabetes Care Products, CAPD Systems and Pharmaceuticals; Cardiac & Vascular Products include Interventional Systems, Cardiovascular Systems and Artificial Vascular Grafts. Terumo's Blood Transfusion products include blood bags, blood filter, filter in line, blood administration sets and apheresis, while consumer healthcare products include ear thermometer, electronic thermometer, basal body thermometer, electronic sphygmomanometer, urine test strip and leg compression stockings. Terumo Corporation is headquartered in Tokyo, Japan. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $226.537B | 27.97 |
Boston Scientific (BSX) | United States | $156.388B | 42.28 |
Stryker (SYK) | United States | $146.977B | 31.60 |
EssilorLuxottica (ESLOY) | France | $141.159B | 0.00 |
Medtronic (MDT) | Ireland | $119.009B | 17.68 |
Lonza Group Ag (LZAGY) | Switzerland | $47.863B | 0.00 |
Haleon (HLN) | United Kingdom | $43.958B | 28.56 |
GE HealthCare Technologies (GEHC) | United States | $42.167B | 20.54 |
Agilent Technologies (A) | United States | $38.420B | 25.46 |
ResMed (RMD) | United States | $34.217B | 26.35 |
Koninklijke Philips (PHG) | Netherlands | $26.497B | 20.28 |
Zimmer Biomet Holdings (ZBH) | United States | $20.011B | 12.56 |
Insulet (PODD) | United States | $19.680B | 78.37 |
Baxter (BAX) | United States | $15.736B | 10.24 |
Sunny Optical Technology (SNPTF) | China | $11.331B | 0.00 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.236B | 0.00 |
BellRing Brands (BRBR) | United States | $9.837B | 36.87 |
Demant (WILYY) | Denmark | $7.946B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.760B | 26.88 |
Lantheus Holdings (LNTH) | United States | $5.558B | 12.91 |
Prestige Consumer Healthcare (PBH) | United States | $4.260B | 20.33 |
ICU Medical (ICUI) | United States | $3.921B | 37.33 |
Envista Holdings (NVST) | United States | $3.723B | 29.62 |
Perrigo (PRGO) | Ireland | $3.341B | 9.84 |
Haemonetics (HAE) | United States | $3.133B | 14.74 |
Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
GN Store Nord (GNNDY) | Denmark | $2.963B | 19.97 |
QuidelOrtho (QDEL) | United States | $2.729B | 22.92 |
LeMaitre Vascular (LMAT) | United States | $2.218B | 53.91 |
Neogen (NEOG) | United States | $2.133B | 24.58 |
AtriCure (ATRC) | United States | $1.996B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.528B | 26.67 |
InMode (INMD) | Israel | $1.308B | 10.94 |
BioLife Solutions (BLFS) | United States | $1.288B | 0.00 |
AdaptHealth (AHCO) | United States | $1.181B | 8.44 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.061B | 0.00 |
Phibro Animal Health (PAHC) | United States | $1.044B | 16.01 |
Curaleaf Holdings (CURLF) | Canada | $0.978B | 0.00 |
Evolus (EOLS) | United States | $0.933B | 0.00 |
CeriBell (CBLL) | United States | $0.768B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.725B | 0.00 |
Owens & Minor (OMI) | United States | $0.574B | 4.49 |
VAREX IMAGING (VREX) | United States | $0.547B | 23.70 |
Valneva SE (VALN) | France | $0.542B | 0.00 |
Omeros (OMER) | United States | $0.532B | 0.00 |
SNDL (SNDL) | Canada | $0.489B | 0.00 |
Surmodics (SRDX) | United States | $0.487B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.459B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.373B | 0.00 |
ZimVie (ZIMV) | United States | $0.363B | 30.56 |
Aurora Cannabis (ACB) | Canada | $0.346B | 63.10 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.346B | 0.00 |
Cerus (CERS) | United States | $0.344B | 0.00 |
Quanterix (QTRX) | United States | $0.310B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.306B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.305B | 29.00 |
Canopy Growth (CGC) | Canada | $0.294B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.293B | 19.65 |
Biote (BTMD) | United States | $0.249B | 5.45 |
Zynex (ZYXI) | United States | $0.240B | 50.27 |
INLIF (INLF) | $0.237B | 0.00 | |
Sanuwave Health (SNWV) | United States | $0.229B | 3.21 |
High Tide (HITI) | Canada | $0.214B | 0.00 |
Brainsway (BWAY) | Israel | $0.213B | 113.00 |
Utah Medical Products (UTMD) | United States | $0.207B | 15.46 |
TerrAscend (TSNDF) | Canada | $0.175B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
MacroGenics (MGNX) | United States | $0.161B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.160B | 0.00 |
FitLife Brands (FTLF) | United States | $0.140B | 17.51 |
Jin Medical (ZJYL) | China | $0.135B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.128B | 0.00 |
Fonar (FONR) | United States | $0.103B | 11.61 |
Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
Veru (VERU) | United States | $0.079B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
Exagen (XGN) | United States | $0.075B | 0.00 |
InterCure (INCR) | Israel | $0.074B | 0.00 |
Cytosorbents (CTSO) | United States | $0.071B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.060B | 30.83 |
MariMed (MRMD) | United States | $0.057B | 0.00 |
Apyx Medical (APYX) | United States | $0.056B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.053B | 0.00 |
United-Guardian (UG) | United States | $0.050B | 14.32 |
ImmuCell (ICCC) | United States | $0.045B | 0.00 |
Modular Medical (MODD) | United States | $0.045B | 0.00 |
Safety Shot (SHOT) | United States | $0.033B | 0.00 |
Nephros (NEPH) | United States | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
Flora Growth (FLGC) | United States | $0.012B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Agape ATP (ATPC) | $0.004B | 0.00 | |
Senestech (SNES) | United States | $0.004B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |